CD14 and Salt-Sensitive Hypertension
CD14 and Salt-Sensitive Hypertension
批准号:
10633269
负责人:
David L. Mattson
金额:
$49.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2026-06-30
关键词:
AddressAnimal ModelAntihypertensive AgentsAttenuatedBone MarrowCardiovascular DiseasesCell SeparationCellsCerebrovascular DisordersClinicalConsciousDahl Hypertensive RatsDataDevelopmentDiseaseDiuresisExhibitsFemaleFree RadicalsGeneticGenetic EngineeringGrantHematopoieticHumanHypertensionImmuneImmunityIn VitroIndividualInflammationInflammatoryIntakeInterleukin-1 betaKidneyKidney DiseasesKnowledgeLeadLeukocytesMacrophageMediatingMethodologyModelingNADPH OxidaseNatriuresisOrganPathogenesisPhagocytesPlasmaPopulationProcessProductionProteinsRat StrainsRattusReactive Oxygen SpeciesResistanceResistant HypertensionRisk FactorsRoleSignal TransductionSodium ChlorideT cell therapyT-Cell ActivationT-LymphocyteTLR4 geneTestingTherapeuticWorkblood pressure elevationcardiovascular risk factorcytokineexperimental studyhemodynamicshypertensivehypertensivesin vivoinsightmalemodifiable riskmortalityneutrophil cytosol factor 67Knovelpressureprotective effectreceptorrenal damageresponsesalt sensitivesalt sensitive hypertensionsalureticsex
中文摘要
摘要
高血压是心血管、脑血管和肾脏疾病的主要可改变的危险因素,并且
是世界上导致疾病和死亡的最大个体因素。盐敏感型高血压
占高血压人口30%-50%的个体比有盐分的受试者死亡率更高。
顽固性高血压并表现出肾脏终末器官损害。我们最近发现了一种新的抗高血压药物
分化簇14(CD14)介导的机制在女性中相对增强
男性。CD14是Toll样受体4(TLR4)的联合受体。有趣的是,CD14在卵巢癌中的表达
心血管疾病和高血压患者外周血白细胞和血浆CD14蛋白水平升高
人类。我们认为肾脏巨噬细胞中的CD14信号与TLR4和Leads的作用相反
抑制自由基和促炎细胞因子IL-1β的释放,钝化T细胞的激活,以及
减轻盐敏感型高血压。
这个项目是基于我们独特的(有些令人惊讶的)观察到的CD14的基因缺失,
该基因在喂食高盐的Dahl盐敏感(SS)大鼠肾脏的巨噬细胞中上调,导致
促炎症细胞因子IL-1、β和活性氧的释放增加。值得注意的是,我们观察到
缺乏CD14(SSCD14-/-)的雌性Dahl SS大鼠表现出放大的盐敏感型高血压和肾脏损害
与野生型窝种相比。进一步的研究表明,CD14缺失的影响是依赖的
在造血细胞上,在雌性中扩增,在缺乏吞噬NADPH氧化酶2(NOX2)的大鼠中消除。
这些令人兴奋的数据表明,CD14在盐敏感的发育过程中发挥了意想不到的性别依赖性作用。
高血压和肾脏损伤。这项提议将检验这样一种假设,即维生素A的降压作用
肾脏巨噬细胞中的CD14导致肾脏T细胞活性降低,减弱对盐的敏感性
高血压,并减少肾终末器官损害。这一假设将在三个具体目标中得到解决。
目标1将阐述CD14对盐敏感型高血压和
相关的肾脏损伤包括抑制巨噬细胞中TLR4介导的信号转导。目标2将解决
巨噬细胞中NOX2升高调节高盐喂养Dahl SS大鼠血压升高的假说,
这种效应在女性中被CD14减弱,在男性中被TLR4放大。目标3将解决以下假设
TLR4的降压作用和CD14的降压作用是由相应的
自由基依赖过程中压力、利钠-利尿和肾内血流动力学的变化
在巨噬细胞和T细胞中由NOX2释放。该提案采用了体外和体内方法来
使用为这笔赠款开发的独特的、基因工程的大鼠品系来解决这个假说,新的免疫
细胞移植方法,以及评估清醒大鼠血流动力学变量的最新方法学。
英文摘要
SUMMARY
Hypertension is a primary modifiable risk factor for cardiovascular, cerebrovascular, and renal disease, and is
the largest individual contributing factor to disease and mortality in the world. Salt-sensitive hypertensive
individuals, who comprise 30-50% of the hypertensive population, have greater mortality than subjects with salt-
resistant hypertension and exhibit renal end-organ damage. We recently discovered a novel anti-hypertensive
mechanism that is mediated by Cluster of Differentiation 14 (CD14) and enhanced in females relative to
males. CD14 is a co-receptor with Toll Like Receptor 4 (TLR4). Interestingly, the expression of CD14 in
leukocytes and level of plasma CD14 protein are increased in cardiovascular disease and hypertension in
humans. We propose that CD14 signaling in macrophages in the kidney opposes the effects of TLR4 and leads
to the attenuated release of free radicals and the proinflammatory cytokine Il-1β, blunted T cell activation, and
attenuated salt-sensitive hypertension.
This project is based upon our unique (and somewhat surprising) observation that genetic deletion of CD14,
which is upregulated in macrophages in the kidney of Dahl Salt-Sensitive (SS) rats fed high salt, leads to
increased release of the proinflammatory cytokine Il-1β and reactive oxygen species. Remarkably, we observed
that female Dahl SS rats lacking CD14 (SSCD14-/-) exhibit amplified salt-sensitive hypertension and renal damage
compared to wild type littermates. Further study demonstrated that the effects of CD14 deletion are dependent
on hematopoietic cells, amplified in females, and eliminated in rats lacking phagocytic NADPH oxidase 2 (NOX2).
These exciting data indicate an unexpected, sex-dependent role of CD14 in the development of salt-sensitive
hypertension and renal damage. This proposal will test the hypothesis that the anti-hypertensive effects of
CD14 in macrophages in the kidney lead to decreased activation of T cells in the kidney, attenuated salt-sensitive
hypertension, and decreased renal end-organ damage. The hypothesis will be addressed in three specific aims.
Aim 1 will address the hypothesis that the protective effects of CD14 against salt-sensitive hypertension and
associated renal damage involve inhibition of TLR4-mediated signaling in macrophages. Aim 2 will address the
hypothesis that elevated NOX2 in macrophages mediate elevated blood pressure in Dahl SS rats fed high salt,
an effect attenuated in females by CD14 and amplified in males by TLR4. Aim 3 will address the hypothesis that
the pro-hypertensive effects of TLR4 and the anti-hypertensive effects of CD14 are mediated by corresponding
changes in pressure natriuresis-diuresis and intrarenal hemodynamics in a process dependent upon free radicals
released from NOX2 in macrophages and T cells. The proposal employs in vitro and in vivo approaches to
address the hypothesis using unique, genetically-engineered rat strains developed for this grant, novel immune
cell transfer approaches, and state-of-the art methodology to assess hemodynamic variables in conscious rats.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.34067/kid.0000000000000210
发表时间:
2023-08-01
期刊:
Kidney360
影响因子:
--
作者:
[Mattson DL, Dasinger JH, Abais-Battad JM]
通讯作者:
Abais-Battad JM
Functional NADPH oxidase 2 in T cells amplifies salt-sensitive hypertension and associated renal damage.
T 细胞中的功能性 NADPH 氧化酶 2 会加剧盐敏感性高血压和相关的肾损伤。
DOI:
10.1152/ajprenal.00014.2023
发表时间:
2023
期刊:
American journal of physiology. Renal physiology
影响因子:
--
作者:
[Walton,SamuelD, Dasinger,JohnHenry, Burns,EmilyC, Cherian-Shaw,Mary, Abais-Battad,JustineM, Mattson,DavidL]
通讯作者:
Mattson,DavidL
Gut Metabolites, T cells, and Salt-Sensitive Hypertension
-
批准号:10568068
-
项目类别:
-
资助金额:$55.89万
-
财政年份:2023
-
负责人:David L. Mattson
-
依托单位:
CD14 and Salt-Sensitive Hypertension
-
批准号:10522446
-
项目类别:
-
资助金额:$49.8万
-
财政年份:2022
-
负责人:David L. Mattson
-
依托单位:
Role of CD247 in Salt-Sensitive Hypertension and Renal Disease
-
批准号:8508937
-
项目类别:
-
资助金额:$32.11万
-
财政年份:2012
-
负责人:David L. Mattson
-
依托单位:
Role of CD247 in Salt-Sensitive Hypertension and Renal Disease
-
批准号:8396503
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2012
-
负责人:David L. Mattson
-
依托单位:
Role of CD247 in Salt-Sensitive Hypertension and Renal Disease
-
批准号:8730147
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2012
-
负责人:David L. Mattson
-
依托单位:
Renal Infiltration of Immune Cells Mediates Hypertension
-
批准号:8230994
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2011
-
负责人:David L. Mattson
-
依托单位:
Renal Infiltration of Immune Cells Mediates Hypertension
-
批准号:7389280
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2008
-
负责人:David L. Mattson
-
依托单位:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
-
批准号:7502047
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2003
-
负责人:David L. Mattson
-
依托单位:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
-
批准号:7671452
-
项目类别:
-
资助金额:$25.24万
-
财政年份:2003
-
负责人:David L. Mattson
-
依托单位:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
-
批准号:8136966
-
项目类别:
-
资助金额:$24.74万
-
财政年份:2003
-
负责人:David L. Mattson
-
依托单位:
Arginine Uptake Mechanisms Regulate Nitric Oxide in the Renal Vasculature
-
批准号:7918741
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2003
-
负责人:David L. Mattson
-
依托单位:
BIOCHEMICAL/MICROSCOPY
-
批准号:8726477
-
项目类别:
-
资助金额:$26.26万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
Immune Cells and Hypertension
-
批准号:9417468
-
项目类别:
-
资助金额:$48.49万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
Renal Infiltration of Immune Cells Mediates Hypertension
-
批准号:8106999
-
项目类别:
-
资助金额:$34.82万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
Hypertensive Mechanisms of T-Lymphocytes in the Kidney
-
批准号:9091604
-
项目类别:
-
资助金额:$43.96万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
BIOCHEMICAL/MICROSCOPY
-
批准号:8866453
-
项目类别:
-
资助金额:$26.32万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
Hypertensive Mechanisms of T-Lymphocytes in the Kidney
-
批准号:8866450
-
项目类别:
-
资助金额:$43.49万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
Hypertensive Mechanisms of T-Lymphocytes in the Kidney
-
批准号:8726474
-
项目类别:
-
资助金额:$43.09万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
Renal Infiltration of Immune Cells Mediates Hypertension
-
批准号:8377699
-
项目类别:
-
资助金额:$24.47万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
Hypertensive Mechanisms of T-Lymphocytes in the Kidney
-
批准号:8592304
-
项目类别:
-
资助金额:$41.85万
-
财政年份:--
-
负责人:David L. Mattson
-
依托单位:
海外基金